Sanders and coworkers (2014) demonstrated the inactivation of IPF fibroblasts as well as the amelioration of experimental pulmonary fibrosis in response to global HDAC inhibition by SAHA [164]. This evidence concerns the gene HDAC9 and idiopathic pulmonary fibrosis.